Literature DB >> 14630446

Lyme borreliosis.

Gerold Stanek1, Franc Strle.   

Abstract

Lyme borreliosis is the most common tick-transmitted disease in the northern hemisphere and is caused by spirochaetes of the Borrelia burgdorferi species complex. A complete presentation of the disease is an extremely unusual observation in which a skin lesion results from a tick bite and is followed by heart and nervous system involvement, and later on by arthritis. Late involvement of eye, nervous system, joints, and skin can also occur. The only sign that enables a reliable clinical diagnosis of Lyme borreliosis is erythema migrans. Other features of some diagnostic value are earlobe lymphocytoma, meningoradiculoneuritis (Garin-Bujadoux-Bannwarth syndrome), and acrodermatitis chronica atrophicans. The many other symptoms and signs have little diagnostic value. Microbial or serological confirmation of borrelial infection is needed for all manifestations of the disease except for typical early skin lesions. However, even erythema migrans might not be pathognomonic for Lyme borreliosis, especially in the southern part of the USA where there is no microbiological evidence for infection with the agent. Treatment with antibiotics is beneficial for all stages of Lyme borreliosis, but is most successful early in the course of the illness. Prevention relies mainly on avoiding exposure to tick bites but there is some interest in chemoprophylaxis and also in vaccine development following initial disappointments.

Entities:  

Mesh:

Year:  2003        PMID: 14630446     DOI: 10.1016/S0140-6736(03)14798-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  81 in total

Review 1.  Recent developments in Bell's palsy.

Authors:  N Julian Holland; Graeme M Weiner
Journal:  BMJ       Date:  2004-09-04

2.  Preventing broken Borrelia telomeres: ResT couples dual hairpin telomere formation with product release.

Authors:  Julien Briffotaux; Kerri Kobryn
Journal:  J Biol Chem       Date:  2010-10-14       Impact factor: 5.157

3.  Mercury exposure as a model for deviation of cytokine responses in experimental Lyme arthritis: HgCl2 treatment decreases T helper cell type 1-like responses and arthritis severity but delays eradication of Borrelia burgdorferi in C3H/HeN mice.

Authors:  C Ekerfelt; M Andersson; A Olausson; S Bergström; P Hultman
Journal:  Clin Exp Immunol       Date:  2007-08-02       Impact factor: 4.330

4.  Comparison of immunofluorescence assay (IFA) and LIAISON in patients with different clinical manifestations of Lyme borreliosis.

Authors:  Tjasa Cerar; Eva Ruzic-Sabljic; Joze Cimperman; Franc Strle
Journal:  Wien Klin Wochenschr       Date:  2006-11       Impact factor: 1.704

5.  Humoral immune responses in patients with Lyme neuroborreliosis.

Authors:  Tjasa Cerar; Katarina Ogrinc; Franc Strle; Eva Ruzić-Sabljić
Journal:  Clin Vaccine Immunol       Date:  2010-02-17

6.  Multiple cranial nerve involvement in Bannwarth's syndrome.

Authors:  Marika Vianello; Giancarlo Marchiori; Bruno Giometto
Journal:  Neurol Sci       Date:  2008-05-16       Impact factor: 3.307

7.  Allozyme polymorphism of Mdh and alpha-Gpdh in Ixodes ricinus populations: comparison of borreliae-infected and uninfected ticks.

Authors:  Zeljko Radulović; Marija Milutinović; Marko Andelković; Zoran Vujcić; Snezana Tomanović; Natasa Bozić; Dragoslav Marinković
Journal:  Exp Appl Acarol       Date:  2006-10-28       Impact factor: 2.132

8.  BBK07, a dominant in vivo antigen of Borrelia burgdorferi, is a potential marker for serodiagnosis of Lyme disease.

Authors:  Adam S Coleman; Utpal Pal
Journal:  Clin Vaccine Immunol       Date:  2009-09-23

9.  Investigation of the genes involved in antigenic switching at the vlsE locus in Borrelia burgdorferi: an essential role for the RuvAB branch migrase.

Authors:  Ashley R Dresser; Pierre-Olivier Hardy; George Chaconas
Journal:  PLoS Pathog       Date:  2009-12-04       Impact factor: 6.823

10.  Mapping of hormones and cortisol responses in patients after Lyme neuroborreliosis.

Authors:  Ivar Tjernberg; Martin Carlsson; Jan Ernerudh; Ingvar Eliasson; Pia Forsberg
Journal:  BMC Infect Dis       Date:  2010-02-05       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.